Immune Correlates of Protection from Filovirus Efficacy Studies in Non-Human Primates

Immune Correlates of Protection from Filovirus Efficacy Studies in Non-Human Primates

Non-human primate (NHP) efficacy data for several Ebola virus (EBOV) vaccine candidates exist, but definitive correlates of protection (CoP) have not been demonstrated, although antibodies to the filovirus glycoprotein (GP) antigen and other immunological endpoints have been proposed as potential Co...

Full description

Bibliographic Details
Main Authors:	Cheryl A. Triplett, Nancy A. Niemuth, Christopher Cirimotich, Gabriel Meister, Mimi Guebre-Xabier, Nita Patel, Mike Massare, Greg Glenn, Gale Smith, Kendra J. Alfson, Yenny Goez-Gazi, Ricardo Carrion
Format:	Article
Language:	English
Published:	MDPI AG 2022-08-01
Series:	Vaccines
Subjects:	correlates of protection PsVNA ELISA Marburg virus Sudan virus Ebola virus
Online Access:	https://www.mdpi.com/2076-393X/10/8/1338

Similar Items

Adapting Simon’s Two-Stage Design for Efficient Screening of Filovirus Vaccines in Non-Human Primates
by: Nancy A. Niemuth, et al.
Published: (2022-07-01)

Recombinant Protein Filovirus Vaccines Protect Cynomolgus Macaques From Ebola, Sudan, and Marburg Viruses
by: Axel T. Lehrer, et al.
Published: (2021-08-01)

Bridging Animal and Human Data in Pursuit of Vaccine Licensure
by: Courtney L. Finch, et al.
Published: (2022-08-01)

Obtaining and Immunologic Characterization of Filoviruses Recombinant Proteins VP40 and NP
by: A. V. Ivanova, et al.
Published: (2010-08-01)

Standardization of the Filovirus Plaque Assay for Use in Preclinical Studies
by: Gene G. Olinger, et al.
Published: (2012-12-01)

Assays for the Evaluation of the Immune Response to Marburg and Ebola Sudan Vaccination—Filovirus Animal Nonclinical Group Anti-Marburg Virus Glycoprotein Immunoglobulin G Enzyme-Linked Immunosorbent Assay and a Pseudovirion Neutralization Assay
by: Thomas L. Rudge, et al.
Published: (2022-07-01)

Serological Evidence of Filovirus Infection in Nonhuman Primates in Zambia
by: Katendi Changula, et al.
Published: (2021-06-01)

Protection against Marburg Virus and Sudan Virus in NHP by an Adenovector-Based Trivalent Vaccine Regimen Is Correlated to Humoral Immune Response Levels
by: Machteld M. Tiemessen, et al.
Published: (2022-08-01)

Approaches to demonstrating the effectiveness of filovirus vaccines: Lessons from Ebola and COVID-19
by: Marion F. Gruber, et al.
Published: (2023-02-01)

Filoviruses: A Compendium of 40 Years of Epidemiological, Clinical, and Laboratory Studies
by: Pierre E. Rollin
Published: (2009-12-01)

Virus inoculation and treatment regimens for evaluating anti-filovirus monoclonal antibody efficacy in vivo
by: Logan Banadyga, et al.
Published: (2019-06-01)

Selection of Filovirus Isolates for Vaccine Development Programs
by: Daniel N. Wolfe, et al.
Published: (2021-09-01)

Serologic Evidence of Fruit Bat Exposure to Filoviruses, Singapore, 2011–2016
by: Eric D. Laing, et al.
Published: (2018-01-01)

Development of a Well-Characterized Cynomolgus Macaque Model of Marburg Virus Disease for Support of Vaccine and Therapy Development
by: Kendra J. Alfson, et al.
Published: (2022-08-01)

Challenges, Progress, and Opportunities: Proceedings of the Filovirus Medical Countermeasures Workshop
by: Rona Hirschberg, et al.
Published: (2014-07-01)

Vaccines against Ebola virus and Marburg virus: recent advances and promising candidates
by: John J. Suschak, et al.
Published: (2019-10-01)

Filoviridae Infections
by: Orhan BAYLAN, et al.
Published: (1997-09-01)

Ebola and Marburg virus matrix layers are locally ordered assemblies of VP40 dimers
by: William Wan, et al.
Published: (2020-10-01)

Filovirus RefSeq Entries: Evaluation and Selection of Filovirus Type Variants, Type Sequences, and Names
by: Jens H. Kuhn, et al.
Published: (2014-09-01)

Correlates of Immunity to Filovirus Infection
by: Sina Bavari, et al.
Published: (2011-06-01)

A Limited Structural Modification Results in a Significantly More Efficacious Diazachrysene-Based Filovirus Inhibitor
by: Rekha G. Panchal, et al.
Published: (2012-08-01)

The Toll-Like Receptor 4 Antagonist Eritoran Protects Mice from Lethal Filovirus Challenge
by: Patrick Younan, et al.
Published: (2017-05-01)

Automation of Infectious Focus Assay for Determination of Filovirus Titers and Direct Comparison to Plaque and TCID<sub>50</sub> Assays
by: Patrick T. Keiser, et al.
Published: (2021-01-01)

Intramuscular Exposure of <i>Macaca fascicularis</i> to Low Doses of Low Passage- or Cell Culture-Adapted Sudan Virus or Ebola Virus
by: Kendra J. Alfson, et al.
Published: (2018-11-01)

Marburg and Ebola Virus Infections Elicit a Complex, Muted Inflammatory State in Bats
by: Anitha D. Jayaprakash, et al.
Published: (2023-01-01)

MONOCLONAL ANTIBODIES AND RECOMBINANT PROTEINS OF FILOVIRUSES: IMMUNOCHEMICAL PROPERTIES AND EVALUATION OF THEIR EFFICIENCY FOR IMMUNE DIAGNOSTICS OF MARBURG AND EBOLA VIRUSES
by: E. I. Kazachinskaia, et al.
Published: (2014-07-01)

Interferon-Induced HERC5 Inhibits Ebola Virus Particle Production and Is Antagonized by Ebola Glycoprotein
by: Ermela Paparisto, et al.
Published: (2021-09-01)

The Role of Cytokines and Chemokines in Filovirus Infection
by: Sandra L. Bixler, et al.
Published: (2015-10-01)

Serological evidence of virus infection in Eidolon helvum fruit bats: implications for bushmeat consumption in Nigeria
by: Diego Cantoni, et al.
Published: (2023-11-01)

Mouse Models for Filovirus Infections
by: Kelly L. Warfield, et al.
Published: (2012-09-01)

Comparison of Aerosol Stability of Different Variants of Ebola Virus and Marburg Virus and Virulence of Aerosolised Ebola Virus in an Immune-Deficient Mouse
by: Sophie J. Smither, et al.
Published: (2022-04-01)

Previremic Identification of Ebola or Marburg Virus Infection Using Integrated Host-Transcriptome and Viral Genome Detection
by: Emily Speranza, et al.
Published: (2020-06-01)

Clinical Management of Filovirus-Infected Patients
by: Danielle V. Clark, et al.
Published: (2012-09-01)

Mutation of Hydrophobic Residues in the C-Terminal Domain of the Marburg Virus Matrix Protein VP40 Disrupts Trafficking to the Plasma Membrane
by: Kaveesha J. Wijesinghe, et al.
Published: (2020-04-01)

Development of a Well-Characterized Rhesus Macaque Model of Ebola Virus Disease for Support of Product Development
by: Kendra J. Alfson, et al.
Published: (2021-02-01)

Ecologic and Geographic Distribution of Filovirus Disease
by: A. Townsend Peterson, et al.
Published: (2004-01-01)

Developing Vaccines to Improve Preparedness for Filovirus Outbreaks: The Perspective of the USA Biomedical Advanced Research and Development Authority (BARDA)
by: Lindsay A. Parish, et al.
Published: (2023-06-01)

A Call to Action to Enhance Filovirus Disease Outbreak Preparedness and Response
by: Paul Roddy
Published: (2014-09-01)

Managing Potential Laboratory Exposure to Ebola Virus by Using a Patient Biocontainment Care Unit
by: Mark G. Kortepeter, et al.
Published: (2008-06-01)

Development of a Well-Characterized Cynomolgus Macaque Model of Sudan Virus Disease for Support of Product Development
by: Kendra J. Alfson, et al.
Published: (2022-10-01)